BioXcel Therapeutics (BTAI) said Thursday it will implement a 1-for-16 reverse stock split of its shares to help regain compliance with the minimum bid price listing rule on the Nasdaq.
The company said the shares will start trading on a split-adjusted basis on Feb. 10.
Shares of BioXcel were down about 35% in recent trading.
Price: 0.20, Change: -0.10, Percent Change: -34.76
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。